Coya Therapeutics | 8-K: Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | DEFA14A: Others
Coya Therapeutics | DEFA14A: Others
Coya Therapeutics | DEF 14A: Definitive information statements
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | 8-K: Current report
Coya Therapeutics | DEFA14A: Others
Coya Therapeutics | DEF 14A: Definitive information statements
No Data